| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/10/2001 | EP1140207A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
| 10/10/2001 | EP1140205A2 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase |
| 10/10/2001 | EP1140175A2 Antibodies to truncated vegf-d and uses thereof |
| 10/10/2001 | EP1140174A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 10/10/2001 | EP1140173A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 10/10/2001 | EP1140171A1 Methods and products for regulating lectin complement pathway associated complement activation |
| 10/10/2001 | EP1140158A2 Multi-component vaccine comprising at least two antigens from haemophilus influenzae |
| 10/10/2001 | EP1140155A1 Improved recombinant hepatitis b surface antigen |
| 10/10/2001 | EP1140154A2 Chorionic gonadotropin dna vaccines and methods |
| 10/10/2001 | EP1140153A2 Improvement of tolerance to a xenograft |
| 10/10/2001 | EP1140144A2 Composition of highly purified natural mixtures of type i interferon derived from leukocytes and methods |
| 10/10/2001 | EP1140141A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 10/10/2001 | EP1140138A2 Therapeutic applications of flint polypeptides |
| 10/10/2001 | EP1140137A2 Method for detection and use of differentially expressed genes in disease states |
| 10/10/2001 | EP1140120A2 Human brainiac-5 |
| 10/10/2001 | EP1140045A2 Homer a new target of treating psychiatric disorders |
| 10/10/2001 | EP1140043A2 Transgenic plants comprising a conditionally lethal gene |
| 10/10/2001 | EP1140024A2 Particles for oral delivery of peptides and proteins |
| 10/10/2001 | EP1140023A2 Integrative protein-dna cochleate formulations and methods for transforming cells |
| 10/10/2001 | EP1139751A1 Efficient and stable $i(in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 10/10/2001 | EP1139750A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues |
| 10/10/2001 | EP1139732A1 Msh5 ablated mice and uses therefor |
| 10/10/2001 | EP1012241A4 Screening assays for g protein coupled receptor agonists and antagonists |
| 10/10/2001 | EP0863950B1 Hair dyeing composition |
| 10/10/2001 | EP0840620B1 Il-8 antagonists for treatment of asthma |
| 10/10/2001 | EP0672157B1 Recombinant viruses comprising artificial proteolytic cleavage site |
| 10/10/2001 | EP0668909B1 Transgenic, cross-linked hemoglobin |
| 10/10/2001 | EP0667898B1 Uses of the tau/neurofilament protein kinase pk40 |
| 10/10/2001 | CN1317054A Constitutive disease resistance gene (CDR1) and method of use thereof |
| 10/10/2001 | CN1317052A Proteases fused with variants of streptomyces subtilisin proteases inhibitor |
| 10/10/2001 | CN1317051A HMP-P rinase and TMP-PPase from arabidopsis thaliana and their use in herbicide screening |
| 10/10/2001 | CN1317050A Nucleotide sequences which code for the tal gene |
| 10/10/2001 | CN1317049A Nucleotide sequences which code for the opc A gene |
| 10/10/2001 | CN1317048A Nucleic acid molecules which code for enzymes with fructosyltransferase activity and use thereof |
| 10/10/2001 | CN1317047A GBS toxin receptor |
| 10/10/2001 | CN1317046A Novel receptor protein and method for diagnosing inflammatory diseases by using the same |
| 10/10/2001 | CN1317045A Pharmaceutical uses of NAB1 and NAB2 |
| 10/10/2001 | CN1317044A Nucleic acids encoding proteins involved in sensory transduction |
| 10/10/2001 | CN1317043A Polypeptides and polynucleotides from coagulase-negative staphylocoui |
| 10/10/2001 | CN1317042A Bacteiral strains for production of 2-keto-L-guolonic acid |
| 10/10/2001 | CN1317015A Human anti-factor IX/IXa antibodies |
| 10/10/2001 | CN1317010A Nucleic acids encoding G-protein coupled receptor involved in sensory |
| 10/10/2001 | CN1316910A Composition and methods for regulating lymphocyte activation |
| 10/10/2001 | CN1316878A Method of performing transgenesis |
| 10/10/2001 | CN1316520A Recombination producing of carotenoid especially astaxanthin and its utilized biological material |
| 10/10/2001 | CN1316518A Dual-plasmid gene vaccine resisting against hepatitis B virus, and its preparing process and application |
| 10/10/2001 | CN1316517A Leavo-dikotone reductase gene and its usage |
| 10/10/2001 | CN1316516A Coded rpilk gene nucleotide sequence and its using method |
| 10/10/2001 | CN1316515A Human liver cancer related cancer suppressing protein and its coding sequence |
| 10/10/2001 | CN1316437A Humanized neutralizing generatically engineering Fab antibody of hepatitis A virus |
| 10/10/2001 | CN1316432A Cell death inhibitory albumen |
| 10/10/2001 | CN1072726C Detection of fungal pathogens using polymerase chain reaction |
| 10/10/2001 | CN1072725C In situ PCR amplification system and its containing device and erecting tool |
| 10/10/2001 | CN1072720C Chicken growth hormone gene and expression thereof in E. Coli |
| 10/10/2001 | CN1072719C Isolated nucleic acid sequence coding for tumor rejection antigen precursor |
| 10/10/2001 | CN1072505C Novel antibody system for biological response modifiers |
| 10/09/2001 | US6300545 Transferring microorganismal replicon from agrobacterium to cell; providing replicon, infect cell of plant, monitor plant genome for insertion of replicon |
| 10/09/2001 | US6300544 Cytochrome P450 monooxygenases |
| 10/09/2001 | US6300543 Transformation of zygote, egg or sperm cells and recovery of transformed plants from isolated embryo sacs |
| 10/09/2001 | US6300542 Classification of plant nucleotide sequences; for use in analyzing patterns of expression of the protein products in plant tissue |
| 10/09/2001 | US6300540 Genetically engineered rodent model; for use in diagnosis an treatment of alzheimer's disease |
| 10/09/2001 | US6300539 Model for chronic cerebral inflammation by intracerebral injection of double stranded RNA |
| 10/09/2001 | US6300492 Nucleotide sequences for the prevention of suppression of apoptosis and treatment lymphoma, leukemia, melanoma, ovarian, mammary gland, pancreatic and lung cancers |
| 10/09/2001 | US6300491 Antisense nucleotide for the treatment of allograft defects, cancers and metastasis, inflammatory bowel disease, psoriasis and skin disorders |
| 10/09/2001 | US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers |
| 10/09/2001 | US6300489 Small and cysteine rich antifungal defensin and thionine-like protein genes highly expressed in the incompatible interaction |
| 10/09/2001 | US6300487 Mammalian lysophosphatidic acid acyltransferase |
| 10/09/2001 | US6300485 Myosin IXa and cyclic nucleotide gated channel-15 (CNGC-15) polynucleotides, polypeptides, compositions, methods, and uses thereof |
| 10/09/2001 | US6300484 DNA encoding DP. 75 and a process for its use |
| 10/09/2001 | US6300483 Compositions inducing cleavage of RNA motifs |
| 10/09/2001 | US6300482 MDKI, a novel receptor tyrosine kinase |
| 10/09/2001 | US6300477 Preferential immunoglobulin; for use in treatment of arthritis; for prevention of bacterial and viral infection; for use in gene therapy |
| 10/09/2001 | US6300474 Modified interferons |
| 10/09/2001 | US6300472 Rab proteins |
| 10/09/2001 | US6300470 Amino acid sequence for the treatment of inflammatory pathology; microbiocides |
| 10/09/2001 | US6300321 Compounds, preparation and use for transferring nucleic acids into cells |
| 10/09/2001 | US6300320 Modulation of c-jun using inhibitors of protein kinase C |
| 10/09/2001 | US6300319 Targeted oligonucleotide conjugates |
| 10/09/2001 | US6300318 Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor |
| 10/09/2001 | US6300317 Eukarotic cells, polynucleotide, functional agents, membrane permeability, subcellar localization agents and polynucleotide masking agents |
| 10/09/2001 | US6300310 Amino acid sequence with segments of polypeptides |
| 10/09/2001 | US6300134 RNA transformation vectors derived from a single-component RNA virus and contain an intervening sequence between the cap and the 5′ end |
| 10/09/2001 | US6300133 RNA transformation vectors derived from an uncapped single-component RNA virus |
| 10/09/2001 | US6300132 Antisense inhibition of telomeric repeat binding factor 2 expression |
| 10/09/2001 | US6300129 Transgenic non-human animals for producing heterologous antibodies |
| 10/09/2001 | US6300127 Bone mineralization proteins, DNA, vectors, expression systems |
| 10/09/2001 | US6300126 Nucleotide sequences for use in diagnosis, treatment of genetic disorders; for use in gene therapy |
| 10/09/2001 | US6300120 Phage with nuclear localization signal |
| 10/09/2001 | US6300119 Stretococcal ERS |
| 10/09/2001 | US6300118 Plasmids comprising a genetically altered feline immunodeficiency virus genome |
| 10/09/2001 | US6300117 Proteases from gram-positive organisms |
| 10/09/2001 | US6300116 Modified protease having improved autoproteolytic stability |
| 10/09/2001 | US6300114 Sequences of xylanase and xylanase expression vectors |
| 10/09/2001 | US6300112 β-xylosidase, nucleotide sequence encoding it, and use thereof |
| 10/09/2001 | US6300111 A dna encoding a polypeptide; diagnosis and therapy for cancer, atherosclerosis and the responses of tissues to injury |
| 10/09/2001 | US6300109 A plasmid encoding a methylase and a restriction endonuclease; for producing bacteriophage resistant starter cultures for the production of cheeses and fermented milks |
| 10/09/2001 | US6300108 Controlled electroporation and mass transfer across cell membranes |
| 10/09/2001 | US6300103 A protein isolated from sugar beets; fungicides, viricides, herbicide resistance, nematode resistance, bacteriocides |
| 10/09/2001 | US6300102 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins |
| 10/09/2001 | US6300100 Process for preparing tissue factor pathway inhibitor |